Bibliography
- BARNES PJ: A single inhaler for asthma? Am. J. Respir. Crit. Care Med. (2005) 171:95-97.
- WEDER MM, DONOHUE JF: Role of bronchodilators in chronic obstructive pulmonary disease. Semin. Respir. Crit. Care Med. (2005) 26:221-234
- TROPHY TJ: Phosphodiesterase isoenzymes: molecular targets for novel antiasthma agents. Am. J. Respirat. Crit. Care Med. (1998) 157:351-370.
- VAN SCHALKWYK E, STRYDOM K, WILLIAMS Z et al.: Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J. Allergy Clin. Immunol. (2005) 116:292-298.
- RABE KE, BATEMAN ED, O’DONNELL D et al.: Roflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2005) 366:563-571.
- TIMMER W, LECLERC W, BIRRAUX G et al.: The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo. J. Clin. Pharmacol. (2002) 42:297-303.
- LIPWORTH BJ: Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet (2005) 365:167-175.
- VAN GRUNSVEN PM, VAN SCHAYCK CP, DERENNE JP et al.: Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax (1999) 54:7-14.
- ALSAEEDI A, SIN DD, MCALISTER FA: The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am. J. Med. (2002) 113:59-65.
- SINGH JM, PALDA VA, STANBROOK MB, CHAPMAN KR: Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review. Arch. Intern. Med. (2002) 162:2527-2536.